Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.
about
Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive proteinBiomarkers associated with obstructive sleep apnea: A scoping reviewThe use of sub-mental ultrasonography for identifying patients with severe obstructive sleep apnea.Coronary endothelial function in patients with obstructive sleep apnea.Sleep-disordered breathing and obesity: pathophysiology, complications, and treatmentChanges in obstructive sleep apnea severity, biomarkers, and quality of life after multilevel surgery.Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys.Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysisDiagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis.Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.Sleepiness, inflammation and oxidative stress markers in middle-aged males with obstructive sleep apnea without metabolic syndrome: a cross-sectional study.Obstructive sleep apnea, inflammation, and the metabolic syndromeInflammation in sleep apnea: an update.The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis.Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment.The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort.C-reactive Protein as a Potential Biomarker of Residual Obstructive Sleep Apnea Following Adenotonsillectomy in ChildrenCardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.Association of plasma homocysteine with self-reported sleep apnea is confounded by age: results from the national health and nutrition examination survey 2005-2006.Serum inflammatory markers in obstructive sleep apnea: a meta-analysis.Metabolic consequences of sleep-disordered breathing.Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial.Impact of OSA on biological markers in morbid obesity and metabolic syndrome.Effect of continuous positive airway pressure on C-reactive protein levels in sleep apnea: a meta-analysis.Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease.Impact of mandibular advancement devices on C-reactive protein levels in patients with obstructive sleep apnea.Association between Serum Homocysteine Level and Obstructive Sleep Apnea: A Meta-Analysis.Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis.CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: a meta-analysis.Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept.Analysis of systemic and airway inflammation in obstructive sleep apnea.A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea?Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis.The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome.Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome.Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation.Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients.
P2860
Q27003309-DC6F0486-6B78-4CCF-9741-5E51F4C5BA2BQ28082137-0232F9B1-ABD4-4AD8-AAE1-D4A0C1A780C6Q30454663-F86943E3-61C1-42A4-B297-D7E2DF0B92E6Q33815095-F41246C6-C4F3-4FF4-83A9-FA7FF53BE10AQ33863155-FA15973E-0B25-4DE2-A52A-B86BDDDFAC98Q33870399-603A20A9-61F5-40E0-9803-EA6034F14D61Q33984737-DD2CED4B-6875-437C-8057-D2A43512AF8AQ34066233-3EAB7B99-E5CF-41A9-BFF6-DCF06B3C4272Q34631136-07FC54DE-F320-4A50-AB20-CCB2F6677510Q34697479-599F5AE6-9A74-468C-AEAA-7C9683D0D040Q34697950-8EDA4FD6-E229-441D-80B7-DF7D4307C5BBQ34995623-CFB1CF2B-6AA2-4D86-9836-3FDAE638CA49Q35104040-52AC5329-D2A9-46D0-8564-7EDAABC0B97FQ35137720-FC89E787-B317-4834-8FE1-A02B257BA7E2Q35158154-1CB6B3B6-8808-4E0E-8105-FF82EF2EC8ACQ35769328-78D5A1CB-4A44-4E8E-B5C0-D17C7ABA9D48Q36013859-FF66C344-4551-4214-98DE-23CDBFCDDB23Q36460995-A94DD74B-83F2-4198-B75B-922E545D3D97Q36482623-0579451E-AA4C-4BB8-8EE5-BA6431A54882Q36635197-D520594C-85BD-4FAA-8245-FF7AF4A36547Q37185423-A47D84CF-8998-4B37-933E-3C06683B9C72Q37511434-2A2BCDD9-6A82-4D17-8725-B7ADA61C6F64Q37590174-5E46B4EC-E471-4E37-BD69-86B003C2A5FBQ37590178-270B62CB-A2BD-4B6F-B77E-66935594BE26Q38020106-2ED00094-1DF6-4C2D-B7F3-5F9B3CE7CDEFQ38101728-B86BFA0D-504D-4D83-B9C1-FDDCFA848AADQ38272066-94255317-0301-448F-8E80-F66003664787Q38613162-DB80F610-78A0-49F1-BC90-CC942C8A8E5DQ44698193-80AE13E7-B430-4870-B648-FBE6850C7BA6Q45115317-8C665D29-9DE1-482B-9B64-6B64F9BE5841Q45350785-0997B3D6-D75B-4FD8-A382-BC511FA63E09Q46067976-26D15547-7C10-4168-8F41-3ED52C75071BQ47655185-C35D5555-E79C-46A2-BD05-A6CC4606FEB7Q47819931-3298F21D-C459-4FB7-83B1-B3C98F001DB5Q47918714-7BD3CD31-28E2-457B-A6F9-C4FF0297C629Q47982656-5BAD5B28-E629-48C4-A79F-6F3FE938DB8CQ48033119-9661F55D-9183-48F2-A9E6-8759AE3084E5Q48137999-28EA097B-DC8A-41D2-B15A-0B88A688FC6AQ48157945-C9CCCB83-887A-4163-8104-AFE3AEDEC64EQ48350768-ADB3B282-80E7-4E90-83BA-A49D96D9D48F
P2860
Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular risk markers in ...... and correlation with obesity.
@ast
Cardiovascular risk markers in ...... and correlation with obesity.
@en
type
label
Cardiovascular risk markers in ...... and correlation with obesity.
@ast
Cardiovascular risk markers in ...... and correlation with obesity.
@en
prefLabel
Cardiovascular risk markers in ...... and correlation with obesity.
@ast
Cardiovascular risk markers in ...... and correlation with obesity.
@en
P2093
P2860
P356
P1433
P1476
Cardiovascular risk markers in ...... and correlation with obesity.
@en
P2093
Cormac Taylor
Evelyn Hannigan
Geraldine M Nolan
Sean Cunningham
Silke Ryan
Walter T McNicholas
P2860
P304
P356
10.1136/THX.2006.066720
P407
P577
2007-01-24T00:00:00Z